Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing
Christopher N LaRock1, Simon Döhrmann1, Jordan Todd1
1Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
Abstract:
The antimicrobial peptide LL-37 is generated upon proteolytic cleavage of cathelicidin and limits invading pathogens by directly targeting microbial membranes as well as stimulating innate immune cell function. However, some microbes evade LL-37-mediated defense. Notably, group A Streptococcus (GAS) strains belonging to the hypervirulent M1T1 serogroup are more resistant to human LL-37 than other GAS serogroups. We show that the GAS surface-associated M1 protein sequesters and neutralizes LL-37 antimicrobial activity through its N-terminal domain. M1 protein also binds the cathelicidin precursor hCAP-18, preventing its proteolytic maturation into antimicrobial forms. Exogenous M1 protein rescues M1-deficient GAS from killing by neutrophils and within neutrophil extracellular traps and neutralizes LL-37 chemotactic properties. M1 also binds murine cathelicidin, and its virulence contribution in a murine model of necrotizing skin infection is largely driven by its ability to neutralize this host defense peptide. Thus, cathelicidin resistance is essential for the pathogenesis of hyperinvasive M1T1 GAS.
Insights
Group A Streptococcus (GAS) uses its M1 protein to neutralize the antimicrobial peptide LL-37, evading immune defenses. This resistance mechanism is crucial for the pathogen
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- The antimicrobial peptide LL-37 is a key component of the innate immune system, targeting pathogens.
- Certain Group A Streptococcus (GAS) strains, particularly the hypervirulent M1T1 serogroup, exhibit resistance to LL-37.
- Understanding resistance mechanisms is vital for combating invasive bacterial infections.
Purpose of the Study:
- To investigate how hypervirulent M1T1 GAS evades LL-37-mediated antimicrobial activity.
- To elucidate the role of the GAS M1 protein in neutralizing LL-37 and its precursor.
- To determine the contribution of LL-37 resistance to GAS pathogenesis.
Main Methods:
- In vitro assays to assess LL-37 and cathelicidin binding by the M1 protein.
- Analysis of M1 protein's effect on LL-37 antimicrobial and chemotactic functions.
- In vivo studies using a murine model of necrotizing skin infection to evaluate M1-mediated virulence.
Main Results:
- The GAS M1 protein directly sequesters and neutralizes human LL-37 via its N-terminal domain.
- M1 protein prevents the maturation of the LL-37 precursor (hCAP-18).
- Exogenous M1 protein protects GAS from neutrophil killing and LL-37's immune-stimulating effects.
- M1 protein neutralizes murine cathelicidin, contributing to virulence in a mouse model.
Conclusions:
- Cathelicidin resistance, mediated by the M1 protein, is essential for the pathogenesis of hyperinvasive M1T1 GAS.
- The M1 protein's ability to neutralize host defense peptides is a critical virulence factor.
- Targeting this resistance mechanism could offer new therapeutic strategies against invasive GAS infections.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Clinical Significance of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Adherens Junctions
Adherens Junctions are Dynamic
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA


